Moreover, Qin et al. found that apigenin inhibited the invasion and migration of human hepatocellular carcinoma cells (Bel-7402 and PLC) by suppressing the NF-κB/Snail pathway and reversing the upregulation of epithelial–mesenchymal transition (EMT) marker levels [44]. Here, HSPG2 is linked to hepatocellular carcinoma.